Powder: -20°C for 3 years | In solvent: -80°C for 1 year
1. Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS. 2. Atractylenolide-I significantly sensitizes the response of MyD88(+) EOC cells to paclitaxel by blocking MD-2-mediated TLR4/MyD88 signaling.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 8,500 | |||
5 mg | 在庫あり | ¥ 18,500 | |||
10 mg | 在庫あり | ¥ 30,500 | |||
25 mg | 在庫あり | ¥ 58,000 | |||
50 mg | 在庫あり | ¥ 102,500 | |||
100 mg | 在庫あり | ¥ 143,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 22,000 |
説明 | 1. Atractylenolide-I has an anti-inflammatory effect by inhibiting TNF-α and IL-6 production; ameliorates sepsis syndrome, liver and kidney functions by reduction of pro-inflammatory cytokines and LPS. 2. Atractylenolide-I significantly sensitizes the response of MyD88(+) EOC cells to paclitaxel by blocking MD-2-mediated TLR4/MyD88 signaling. |
植物由来 |
分子量 | 230.3 |
分子式 | C15H18O2 |
CAS No. | 73069-13-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (238.81 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Atractylenolide I 73069-13-3 Angiogenesis Apoptosis Chromatin/Epigenetic Immunology/Inflammation JAK/STAT signaling Stem Cells TNF IL Receptor JAK TLR STAT Janus kinase Inhibitor Toll-like Receptor (TLR) inhibit inhibitor